Form4insider filings, from the source

SEC Form 4 · accession 0000899243-19-002256

FATE THERAPEUTICS INC · FATE

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Amir Nashat
Director
Period of report
Jan 29, 2019
Accepted (ET)
Jan 31, 2019 · 6:00 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001434316

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F2Jan 29, 2019S94,081$14.162D1,529,622ISee Footnote
Common StockF1,F3Jan 29, 2019S1,834$14.1621D1,527,788ISee Footnote
Common StockF1,F4Jan 29, 2019S644$14.162D1,527,144ISee Footnote
Common StockF1,F5Jan 29, 2019S941$14.162D1,526,203ISee Footnote

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses